维亚生物(01873)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01873 维亚生物

休市中 11-06 16:08:52

1.335

-0.020

-1.48%

最高1.355	最低1.280	成交量724.15万
今开1.300	昨收1.355	日振幅5.54%
总市值27.95亿	流通市值27.95亿	总股本20.94亿
成交额958.60万	换手率0.35%	流通股本20.94亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01873","market":"HK","secType":"STK","nameCN":"维亚生物","latestPrice":1.335,"timestamp":1793952532003,"preClose":1.355,"halted":0,"volume":7241500,"delay":0,"changeRate":-0.014760147601476028,"floatShares":2094000000,"shares":2094000000,"eps":0.09,"marketStatus":"休市中","change":-0.02,"latestTime":"11-06 16:08:52","open":1.3,"high":1.355,"low":1.28,"amount":9585999,"amplitude":0.055351,"askPrice":1.335,"askSize":20500,"bidPrice":1.325,"bidSize":6500,"shortable":3,"etf":0,"ttmEps":0.098,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":7,"adr":0,"listingDate":1557331200000,"exchange":"SEHK","adjPreClose":1.355,"openAndCloseTimeList":[[1793928600000,1793937600000],[1793941200000,1793952000000]],"volumeRatio":2.223911307720703,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01873","defaultTab":"news","newsList":[{"id":"1156475036","title":"维亚生物10月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1156475036","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156475036?lang=zh_cn&edition=full","pubTime":"2026-11-04 15:16","pubTimestamp":1793776618,"startTime":"0","endTime":"0","summary":"维亚生物科技控股集团于2026年11月4日公布2026年10月股份变动月报表。报告期内，公司注册股本保持4,000,000,000股，面值每股0.000025美元，法定/注册股本总额为10万美元，较上月无变化。截至2026年10月31日，公司发行在外普通股总数为2,093,553,353股，与上月底持平，当月未发生新增发行、股份回购或注销等变动。期内并无因行使期权导致新股发行或库存股转让。公告由执行董事毛晨签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678375794","title":"维亚生物盘中涨超5%，券商看好AI生物数据基建，CRO板块波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2678375794","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678375794?lang=zh_cn&edition=full","pubTime":"2026-10-28 13:54","pubTimestamp":1793166840,"startTime":"0","endTime":"0","summary":"10月28日，维亚生物(01873.HK)盘中涨超5%，截至13时47分，涨5.16%，报1.32港元/股，成交额254.77万港元。消息面上，10月19日，中邮证券发布医药生物行业研究报告指出，AI4S在分子设计领域已 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261028/c681181035.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261028/c681181035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["AGIX","BK1141","VTHR","AIPO","ARTY","KCE","01873","QTOC","CHAT","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675996315","title":"国海证券：首予维亚生物(01873.HK)“买入”评级 AIDD赋能结构药筛","url":"https://stock-news.laohu8.com/highlight/detail?id=2675996315","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675996315?lang=zh_cn&edition=full","pubTime":"2026-10-14 14:21","pubTimestamp":1791958884,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","BK1141","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674682997","title":"维亚生物盘中跌超5%，医药生物板块回调，CRO概念全线下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2674682997","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674682997?lang=zh_cn&edition=full","pubTime":"2026-10-12 13:43","pubTimestamp":1791783780,"startTime":"0","endTime":"0","summary":"10月12日，维亚生物(01873.HK)盘中跌超5%，截至13时38分，跌5.18%，报1.47港元/股，成交额528.23万港元。消息面上，银河证券认为港股短期结构防御为主，需等待利率信号明朗，建议关注创新药 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261012/c680581858.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261012/c680581858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["000808.SH","BK1576","01873","BK1141","163118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673031279","title":"港股异动 | 维亚生物(01873.HK)午后涨超20% 维亚生物近期与西点药业达成AI驱动反向寻靶研发合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2673031279","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673031279?lang=zh_cn&edition=full","pubTime":"2026-10-06 14:57","pubTimestamp":1791269877,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673031276","title":"港股异动 | 维亚生物(01873)午后涨超20% 维亚生物近期与西点药业达成AI驱动反向寻靶研发合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2673031276","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673031276?lang=zh_cn&edition=full","pubTime":"2026-10-06 14:57","pubTimestamp":1791269877,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，维亚生物午后涨超20%。截至发稿，涨19.59%，报1.77港元，成交额3201.24万港元。消息面上，近日，维亚生物与西点药业达成AI驱动的反向寻靶研发合作。依托维亚生物的Mol2MARS平台，双方围绕药物分子潜在作用机制与靶点系统研究，构建了“AI计算+实验验证”的创新靶点发现研发闭环，为药物的作用机制解析与适应症拓展提供了新的科学依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AIPO","CHAT","BK1576","KCAI","VXUS","BK4588","ARTY","BK4585","BK1141","301130","QTOC","VTHR","AGIX","01873","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199142758","title":"维亚生物9月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1199142758","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199142758?lang=zh_cn&edition=full","pubTime":"2026-10-05 14:51","pubTimestamp":1791183108,"startTime":"0","endTime":"0","summary":"维亚生物科技控股集团于2026年10月5日公布的截至2026年9月30日止月份股份变动月报表显示，公司注册股本未发生变化，面值仍为每股USD 0.000025，注册股份数为4,000,000,000股，对应注册股本USD 100,000。公司已发行股份本月底数为2,093,553,353股，较上月底保持不变，库藏股份亦维持在0股。公司并未进行新的股份发行、回购或注销，股本规模无变化，已满足最低公众持股量要求。截至9月底，公司股本总数保持稳定，未发生发行和回购活动。本次公告由公司执行董事毛晨签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107871637","title":"维亚生物（01873）2026年上半年营收10.07亿元，同比增21.0%，经调整净利润1.28亿元，同比降30.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107871637","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107871637?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:44","pubTimestamp":1790066674,"startTime":"0","endTime":"0","summary":"维亚生物公布2026年上半年财报，期内实现营收人民币10.07亿元，同比增长约21.0%。经调整后的非国际财务报告准则口径净利润为人民币1.28亿元，同比下降约30.1%。经营活动产生的现金流量净额为人民币3.46亿元，而去年同期为1.30亿元。在成本方面，销售及分销费用为人民币0.50亿元，同比下降约13.5%；行政费用为人民币1.22亿元，同比下降约3.2%；研发费用约为人民币0.57亿元，同比增长约41.5%。CDMO及商业化服务收入达人民币6.01亿元，同比增长约47.0%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"维亚生物（01873）2026年上半年营收10.07亿元，同比增21.0%，经调整净利润1.28亿元，同比降30.1%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669139506","title":"医药外包概念盘初走高 昭衍新药（06127）涨6.14% 机构指CXO为医药行业中最亮眼板块之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2669139506","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669139506?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:10","pubTimestamp":1789956632,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药外包概念盘初走高，截至发稿，昭衍新药（06127）涨6.14%，药明生物（02269）涨4.97%，金斯瑞生物科技（01548）涨4.47%，维亚生物（01873）涨3.75%，药明康德（02359）涨3.40%，泰格医药（03347）涨2.52%，康龙化成（03759）涨2.64%。中邮证券研究指，2026中报看，CXO行业是医药行业中最亮眼板块之一。数据上看，CDMO龙头、安评及临床CRO是三条景气主线。估值上看，CDMO龙头公司按2027PE仍处于合理区间，CRO环节公司报表仍处修复阶段，新签高毛利订单待转化，因此表观估值较高，但预计随着订单的逐渐周转快速消化。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992050","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","KURE","LU0516423174.USD","BK1589","LU0561508036.HKD","BK1141","LU0359202008.SGD","LU0181495838.USD","LU3063872942.SGD","02269","LU0052750758.USD","03759","09939","06127","HK0000306701.USD","LU1880383366.USD","LU2242644610.SGD","603127","LU0516422952.EUR","LU0029874905.USD","LU0029874061.USD","02359","01548","LU0043850808.USD","LU0540923850.HKD","LU0516422440.USD","BK1515","BK1583","HK0000320223.HKD","LU0516423091.SGD","LU1794554557.SGD","BK1161","LU0348825331.USD","LU2125910500.SGD","LU0051755006.USD","LU0516422366.SGD","LU0320764599.SGD","BK1610","LU1242518857.USD","LU0359201612.USD","159938","03347","WX","CXO","LU0039217434.USD","LU0456846285.SGD","01873","LU0348766576.USD","SG9999002463.SGD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668919819","title":"CXO板块上扬 昭衍新药（06127）涨5.64%、金斯瑞生物科技（01548）涨4.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668919819","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668919819?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:46","pubTimestamp":1789695974,"startTime":"0","endTime":"0","summary":"金吾财讯 | CXO板块上扬，昭衍新药 涨5.64%，金斯瑞生物科技涨4.78%，维亚生物涨2.15%，泰格医药涨1.93%，药明生物涨1.80%，凯莱英涨1.79%，药明康德涨1.01%，百济神州涨0.95%。中信建投近日研报指，CXO是创新药产业链专业化分工的重要载体，也是连接药物研发与商业化生产的关键基础设施。随着内外需改善逐步传导至订单与业绩，CXO有望进入新一轮增长阶段。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991930","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","CXO","LU1242518857.USD","LU0856984785.SGD","BK1161","LU0634319403.HKD","LU1688375341.USD","LU0029874061.USD","LU0029874905.USD","LU0320764243.SGD","LU0516423174.USD","03347","LU1251922891.USD","LU0588546209.SGD","603127","LU0348825331.USD","BK0216","BK1521","SG9999002562.SGD","LU0052750758.USD","LU0128522744.USD","06127","BK1610","KURE","LU1719994722.HKD","02269","06821","LU2039709279.SGD","LU2242644610.SGD","01548","LU0181495838.USD","WX","02359","LU0039217434.USD","LU0348735423.USD","LU0561508036.HKD","LU3063872942.SGD","IE00B0JY6N72.USD","LU0051755006.USD","LU0456846285.SGD","LU0828237510.HKD","BK1588","LU0228659784.USD","LU0359202008.SGD","LU1242518931.SGD","LU0348827113.USD","LU0469268626.HKD","06160","01873","LU1880383366.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668570069","title":"从中报业绩兑现后的股价回撤到冲高试盘，维亚生物(01873)即将迎来反弹时刻？","url":"https://stock-news.laohu8.com/highlight/detail?id=2668570069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668570069?lang=zh_cn&edition=full","pubTime":"2026-09-17 16:26","pubTimestamp":1789633562,"startTime":"0","endTime":"0","summary":"8月26日盘后，维亚生物发布了其26H1财报，显示其当期收入实现10.07亿元，同比增加20.99%;但与此同时，公司对应净利润1.01亿元，同比减少32.1%。但从K线位置来看，维亚生物股价在9月16日放量反弹后，于次日顺势冲高至1.46港元，正好触及前期套牢压力区。分业务看，报告期内，维亚生物的CRO业务实现收入4.05亿元，同比下滑4.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497353.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668930750","title":"创新药概念走强 金斯瑞生物科技（01548）涨超15% 机构指医药行业基本面持续改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2668930750","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668930750?lang=zh_cn&edition=full","pubTime":"2026-09-17 10:29","pubTimestamp":1789612152,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念走强，截止发稿，金斯瑞生物科技 涨15.29%，维亚生物涨6.32%，凯莱英涨6.08%，泰格医药涨4.86%，昭衍新药涨4.96%。消息面上，国信证券表示，2026年上半年医药行业收入保持稳健增长，利润端实现双位数增长，26Q2盈利增速进一步提升，创新药及产业链维持较高景气。整体来看，2026年上半年医药行业基本面持续改善，盈利修复趋势进一步确认，创新药及CXO等高景气方向表现突出。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","06821","01873","03347","BK1574","01548","BK1191","159992","HK0000320264.USD","HK0000306701.USD","IBBQ","HK0000306685.HKD","BK1141","BK1583","BK1576","HK0000320223.HKD","06978","BK1161","LNGR","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668930626","title":"港股异动 | CRO概念股涨幅居前 AIDD利好催化密集 CXO板块景气度明确上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2668930626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668930626?lang=zh_cn&edition=full","pubTime":"2026-09-17 10:08","pubTimestamp":1789610899,"startTime":"0","endTime":"0","summary":"消息面上，近期，AIDD利好催化密集。招商证券近期研报指出，CXO板块景气度明确上行。今年上半年国内CXO板块营收、归母净利润同比分别增长24.5%、52.7%，利润增速接近上一轮周期高点；在手订单与新签订单全面回暖，龙头上调全年指引。此外，AI制药有望重塑医药研发业态，提升药物研发效率，板块亦将受益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4588","VXUS","BK1576","HK0000320223.HKD","01873","02315","HK0000306701.USD","WX","BK1161","BK1191","BK1141","01548","BK4585","KCAI","HK0000306685.HKD","06821","CXO","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133126787","title":"港股异动｜多数医药外包股走高，金斯瑞生物科技大升10%，维亚生物升4%，泰格医药升3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133126787","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133126787?lang=zh_cn&edition=full","pubTime":"2026-09-17 09:47","pubTimestamp":1789609668,"startTime":"0","endTime":"0","summary":"多数医药外包股走高，金斯瑞生物科技大升10%，维亚生物升 4%，泰格医药升 3%，药明康德、药明生物升 1%。","market":"hk","thumbnail":"https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","01873","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664335531","title":"图解丨南下资金净卖出港股100亿港元，大肆减持腾讯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664335531","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664335531?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:59","pubTimestamp":1788515949,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2265009873.SGD","LU0327786744.USD","LU0878004406.USD","LU1226288170.HKD","LU0229945570.USD","LU0320764599.SGD","LU0181495838.USD","LU0589944569.HKD","IE00BGV7N243.SGD","LU1235295612.USD","LU1226287792.SGD","LU2023250504.SGD","SG9999015952.SGD","IE00BF5LJ272.USD","LU2045819591.USD","SG9999000459.SGD","LU0865486749.SGD","LU0048580855.USD","SG9999004220.SGD","LU2449936058.SGD","LU0823397285.USD","LU1323998911.USD","SG9999014906.USD","BK1526","LU0821914370.USD","LU0348805143.USD","LU0502904849.HKD","BK1149","LU1642822792.SGD","LU2237443465.HKD","LU1883866441.USD","LU0608807946.USD","BK1575","SG9999001846.SGD","LU1044875133.USD","SGXZ51526630.SGD","LU0797268264.HKD","LU0214875030.USD","BK1609","LU2106854487.HKD","LU0107464264.USD","LU0070217475.USD","LU0572944931.SGD","TCEHY","SG9999002828.SGD","ALBmain","IE0032431581.USD","IE00B3M56506.USD","LU2242644610.SGD","BK1608","LU0856984785.SGD","LU1808992512.USD","LU0072913022.USD","LU0328353924.USD","BK1607","IE00B031J352.USD","LU0823039010.USD","LU0708995153.HKD","LU0320764755.SGD","SG9999006597.SGD","LU1769817096.USD","LU0762540952.USD","SG9999014898.SGD","BK1506","LU0784639295.USD","LU1794554557.SGD","LU0700851271.USD","SG9999001226.SGD","IE00B8HQ1Z84.USD","LU0577902611.USD","SG9999007991.SGD","LU0831093199.SGD","BK1615","IE00BQXX3F31.USD","LU1152091168.USD","LU1171460220.USD","LU2362541513.USD","LU0132412106.USD","LU1115378108.SGD","LU0577902298.EUR","LU1961090484.USD","LU2257852520.SGD","LU0708995583.HKD","BK1591","IE00B0169N27.USD","AAXJ","LDEM","LU0203345920.USD","LU1880398554.USD","IE00BZ08YR35.GBP","LU1051768304.USD","06869","LU0096374516.USD","SGXZ90724238.SGD","LU1515016050.SGD","SGXZ62798434.SGD","LU0052750758.USD","LU1974910355.USD","LU0577902371.SGD","LU2476274308.USD","LU0588545904.SGD","LU0210527791.USD","LU2097828474.EUR","LU0370786039.SGD","BK1583","HK0000288743.USD","LU2247934214.USD","LU0127658192.USD","LU1105468828.SGD","LU1224444064.USD","LU1734074674.USD","LU1226288253.USD","LU0577902454.USD","LU2039709279.SGD","LU0672654166.SGD","LU1691799644.USD","LU0348766576.USD","LU1770036033.HKD","LU0651946864.USD","LU2399975544.HKD","SGXZ86797644.SGD","LU0449515922.USD","LU0210526637.USD","LU0197773673.USD","BK1588","LU0823038988.USD","00981","LU1868837565.USD","LU0456846285.SGD","IE00B031HY20.USD","LU0011963245.USD","LU1655091459.SGD","LU1282649810.SGD","LU0164872284.USD","LU0228367735.SGD","LU1720051108.HKD","LU0823413587.USD","BK1614","LU0540923850.HKD","LU1960683339.HKD","HK0000914660.USD","LU0633140560.USD","LU0414403682.SGD","IE0003851619.USD","LU1152091754.HKD","LU0873338254.USD","LU0348788117.USD","IE00BMPRXN33.USD","ODDS","LU2226246903.HKD","EMC","LU2125910849.SGD","LU0594300179.USD","LU0880133367.SGD","LU0293314216.USD","BK1589","LU0640798160.USD","LU0348825331.USD","LU0456842615.SGD","LU0985320562.USD","LU0648948544.HKD","LU1688375341.USD","LU0819123356.HKD","LU2087589342.USD","SG9999003461.SGD","BK1501","IE0003795394.USD","LU1242518857.USD","LU0516422440.USD","LU1675838814.USD","EEMX","LU0762542818.HKD","SG9999001093.SGD","LU0261947096.USD","SG9999001069.SGD","LU0320764243.SGD","LU0348816934.USD","IE0008368742.USD","LU0143863784.USD","LU1048596156.SGD","LU2293587155.HKD","LU1993786604.SGD","BABA","HK0000352382.USD","LU1048484197.HKD","LU1282651121.HKD","LU2237443549.SGD","HK0000286598.CNH","LU0477156797.USD","LU0890818403.SGD","LU0501845795.SGD","LU1282648689.USD","XSOE","LU2462611646.USD","LU0607220059.USD","LU1719994722.HKD","LU2498475776.HKD","LU0348827113.USD","BK1586","LU0235996351.USD","LU0130103400.USD","LU2237443622.USD","LU0886674414.USD","LU1813983027.USD","IE0008368411.USD","SG9999000418.SGD","IE0032834883.USD","SG9999002463.SGD","XIACY","JEMA","LU1211504680.USD","LU0499858438.USD","SG9999015986.USD","BK1502","LU0828238088.HKD","LU2008162690.USD","LU0231483743.USD","LU1008478684.HKD","LU0244354667.USD","LU0264606111.USD","LU1568876251.USD","LU1769817179.HKD","09988","LU1951186391.HKD","LU2317271919.USD","LU0359201612.USD","LU0541501648.USD","688981","LU1366334578.USD","LU0633140727.USD","LU1102505762.USD","LU0329678337.USD","LU0898667661.SGD","LU0329678170.USD","LU0648000940.SGD","LU0384037296.USD","LU0289960550.SGD","HK0001040143.USD","HK0000306685.HKD","HK0000320223.HKD","LU1048588211.SGD","LU1439102457.SGD","LU1282651048.USD","LU0067412154.USD","01548","LU0348723411.USD","LU0469268626.HKD","TCHmain","LU0029874905.USD","LU0188438112.USD","601869","SG9999002562.SGD","GAMR","IE00B97KM107.HKD","01810","IE00B0JY6N72.USD","LU0345776255.USD","LU0516422952.EUR","EMCS","IE0031814852.USD","LU0348735423.USD","LU0203347892.USD","LU0061477393.USD","LU0140636845.USD","LU0488056044.USD","BK1516","LU0871576103.HKD","IE00B0169L03.USD","LU0455707207.USD","LU1880383440.USD","LU0307460666.USD","LU0348814723.USD","LU2097829019.USD","IE00B29SXG58.USD","LU0561508036.HKD","LU2237443382.USD","SGXZ99366536.SGD","IE00B031HW06.USD","LU0543330566.HKD","SG9999018857.SGD","LU0345769631.USD","LU0516423091.SGD","LU0169518387.USD","LU0431992006.USD","BK1531","FDNI","LU0326950275.SGD","IE0009570106.USD","LU0593848301.USD","LU0531971595.HKD","LU1629966141.USD","LU2357305700.SGD","LU0106959298.USD","IE00BPRC5H50.USD","LU0449509016.USD","HK0000165453.HKD","LU0572940350.SGD","SG9999018865.SGD","LU2362540622.SGD","LU1023057109.AUD","SG9999000327.SGD","LU0516423174.USD","SGXZ31699556.SGD","LU0315179316.USD","LU1046422090.SGD","LU0605514214.HKD","LU0634319403.HKD","LU2237443895.HKD","LU1188198961.HKD","LU1328277881.USD","BK1249","BK1610","LU0417516571.SGD","LU1196710864.SGD","LU1303224171.USD","LU0396098781.USD","LU0047713382.USD","LU0675040207.SGD","LU1251922891.USD","BK1521","LU0165289439.USD","HTCD.SI","LU0211331839.USD","LU0831103253.SGD","LU0608807433.USD","LU0738912210.USD","LU0254981946.USD","LU0630378429.USD","LU1718418525.SGD","LU2279701549.SGD","LU0823426308.USD","LU0143863198.USD","LU0345775950.USD","LU0541502299.USD","SG9999006514.SGD","CXSE","LU1226288097.SGD","JADE","LU0106259558.USD","LU0314109678.HKD","IE0003895053.USD","LU0197773160.USD","IE00BQXX3D17.EUR","LU1044876610.USD","LU0828237940.HKD","89988","LU1981816686.USD","LU2097828714.EUR","SG9999014914.USD","LU0868486357.SGD","IE00B5MMRT66.SGD","LU0259732245.USD","LU0348784397.USD","LU0417516738.SGD","LU1282649067.USD","DRGN","GB00BDT5M118.USD","LU1814569148.SGD","LU0642271901.SGD","LU0054450605.USD","LU0791591158.USD","SG9999001051.SGD","LU1242518931.SGD","LU1439103000.SGD","LU0823397103.USD","LU1282649141.HKD","LU1044874839.SGD","LU0072462343.USD","LU0164865239.USD","LU0029875118.USD","BK1576","LU0463099449.HKD","SGXZ81514606.USD","LU0211977185.USD","LU2125910500.SGD","LU1733274390.USD","IE0008369823.USD","LU1810669033.SGD","LU0359201885.HKD","LU0737861772.HKD","SG9999013353.USD","LU0823040885.USD","LU1568876335.HKD","LU2097828631.EUR","LU0261950983.USD","IE00BZ08YT58.USD","BK1574","LU0417516902.SGD","LU0149721374.USD","LU2152927971.USD","HK0000352291.HKD","LU0878005551.USD","BK1141","SG9999001903.USD","LU0080751232.USD","LU0577902538.SGD","IE00BMPRXR70.SGD","LU0456827905.SGD","LU0918141705.HKD","LU0128522157.USD","LU0326948709.USD","LU0630378692.HKD","LU1196710195.USD","LU0762541174.USD","HK0000306701.USD","LU0084288322.USD","LU0823426480.USD","LU0049853897.USD","LU2251237306.USD","LU1328615791.USD","LU0737861699.HKD","SOCL","LU2097828805.USD","KWEB","IE00B543WZ88.USD","IE0001KFT4U8.USD","BK1193","LU0051755006.USD","LU0348783662.USD","IE00BZ08YS42.EUR","LU2778985437.USD","LU1917777945.USD","LU0516422366.SGD","LU1868837722.USD","LU0130518102.USD","LU0509642566.USD","LU1102505929.USD","LU0499858602.USD","LU1548497426.USD","LU1880398471.USD","LU1504937902.USD","LU0228659784.USD","LU0192582467.USD","BIDD","LU0572939691.SGD","ESPO","LU1051769294.HKD","LU1481107354.HKD","SG9999017495.SGD","IE0034224299.USD","LU1226287875.USD","BK1523","MIUmain","IE0008368304.USD","LU2051468812.USD","LU0054237671.USD","LU0251144936.SGD","LU0862451837.USD","LU0348783233.USD","LU0588545730.USD","BK1517","LU2476274720.SGD","LU0117844026.USD","LU1807302812.USD","LU2488822045.USD","LU0882747503.HKD","HK0000288784.HKD","LU0348767384.USD","LU0651947912.USD","LU1956131251.USD","LU0175139822.USD","HK0000151867.HKD","LU0650527681.SGD","LU3227948356.SGD","KURE","LU1064130708.USD","SG9999014674.SGD","HK0001040168.HKD","01873","LU1804176565.USD","LU0918141887.USD","LU0862451753.SGD","FFEM","LU2362541273.HKD","LU0819121731.USD","LU2097828557.USD","HK0000320264.USD","LU1196710351.USD","LU1201861165.SGD","BK1095","LU0149534421.HKD","LU1316542783.SGD","LU1770034418.SGD","LU0543330483.HKD","LU0786609619.USD","LU0531970944.HKD","LU0359202008.SGD","LU0043850808.USD","LU0196878994.USD","LU2237443978.SGD","BK1142","LU0287142896.SGD","HK0000914686.HKD","LU0588545490.SGD","LU2177674079.SGD","LU1224709979.USD","LU3063872942.SGD","LU0791590937.USD","LU2294711473.HKD","LU1366334651.USD","LU0979878070.USD","LU2251237488.HKD","LU0128522744.USD","LU1733274473.HKD","09926","LU0106252389.USD","LU2133065610.SGD","SG9999015978.USD","LU2148510915.USD","LU1720050803.USD","LU1831875114.USD","LU0269904917.USD","LU1880383366.USD","LU0039217434.USD","LU0828237510.HKD","LU0683595622.HKD","LU0048597586.USD","LU0611395673.USD","LU2279858448.HKD","LU1064131003.USD","LU0588546209.SGD","IE00BQXX3C00.GBP","SG9999001689.USD","LU0164880469.USD","HK0000107257.USD","BK1161","LU0163747925.USD","TCHI","LU1720051017.SGD","SG9999014880.SGD","LU0441854154.USD","LU0594300419.USD","HXXD.SI","IE00B067MR52.USD","00700","HBBD.SI","LU1725190679.HKD","LU0315178854.USD","LU0972618739.USD","BK1618","LU1868838027.USD","LU0823413660.USD","IE00B8L5B284.USD","LU0210533765.USD","SG9999015945.SGD","LU0823041008.USD","BK1584","LU0117841782.USD","LU1785774172.SGD","81810","BKF","LU0049112450.USD","LU0173614495.USD","LU0048388663.USD","LU0345769128.USD","LU1226287529.USD","BK1163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143506639","title":"维亚生物2026年8月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1143506639","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143506639?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:13","pubTimestamp":1788513214,"startTime":"0","endTime":"0","summary":"维亚生物科技控股集团于2026年9月4日发布截至2026年8月31日的股份变动月报表。报告期内，公司法定/注册股本總额保持在4,000,000,000股普通股，面值为每股0.000025美元，总注册股本维持在100,000美元。期权与激励计划方面，公告显示公司已有首发前股份奖励计划与首次公开发售后购股权计划。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662227507","title":"港股异动 | 维亚生物(01873.HK)一度跌超10% 上半年经调整净利润同比跌三成 CRO业务收入有所下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662227507","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662227507?lang=zh_cn&edition=full","pubTime":"2026-08-27 11:38","pubTimestamp":1787801916,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01873","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154186272","title":"维亚生物发布2026年中期业绩：AI引领药物研发新范式，CDMO商业化生产加速营收增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1154186272","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154186272?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:58","pubTimestamp":1787756293,"startTime":"0","endTime":"0","summary":"维亚生物公布了其2026年中期业绩报告，揭示了公司在人工智能驱动下的药物研发领域所开创的全新格局。与此同时，CDMO业务的商业化制造能力正成为推动营收攀升的关键引擎。报告显示，AI技术的深度应用正在重塑药物研发的传统路径，为行业带来一场静默而深刻的变革。在另一条战线上，CDMO板块的商业化生产呈现出强劲的扩张势头。展望下半年，随着AI模型的进一步迭代以及商业化项目的陆续交付，公司或将在既有轨道上驶向更广阔的蓝海。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01873","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154969936","title":"维亚生物(01873)2026年中期业绩：营收10.07亿元，经调整净利润1.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154969936","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154969936?lang=zh_cn&edition=full","pubTime":"2026-08-26 18:26","pubTimestamp":1787740013,"startTime":"0","endTime":"0","summary":"维亚生物披露截至2026年6月30日止六个月的财务数据，营收约10.07亿元，同比增长21.0%。期内经调整非国际财务报告准则净利润约1.28亿元，同比下降30.1%，对应净利率从上年同期的22.1%降至12.7%。同期毛利约3.42亿元，毛利率为34.0%，对比上年同期的40.8%有所下滑。药物发现服务板块报告期业务收入约4.05亿元，同比减少4.2%，如扣除汇率因素则降幅约1.2%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"维亚生物(01873)2026年中期业绩：营收10.07亿元，经调整净利润1.28亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662790813","title":"维亚生物(01873.HK)发布中期业绩，经调整净利润1.28亿元 同比减少30.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662790813","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662790813?lang=zh_cn&edition=full","pubTime":"2026-08-26 18:26","pubTimestamp":1787739967,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01873","BK1141","BK1576"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivabiotech.com","stockEarnings":[{"period":"1week","weight":0.068},{"period":"1month","weight":-0.2101},{"period":"3month","weight":-0.0729},{"period":"6month","weight":-0.1604},{"period":"1year","weight":-0.3791},{"period":"ytd","weight":-0.2583}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"维亚生物科技控股集团是一家投资控股公司。该公司有两个分部。药物发现服务分部提供就临床前创新药物开发向生物科技及制药客户提供基于结构的药物发现服务。同研发生产组织务（CDMO）及商业化服务分部从事小分子原料药及中间体的合同研发生产服务以及买卖原料药、中间体及制剂。该公司主要在美国、中国、欧洲和其他地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.080145},{"month":2,"riseRate":0.285714,"avgChangeRate":0.018359},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.001599},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.030961},{"month":5,"riseRate":0.571429,"avgChangeRate":0.174922},{"month":6,"riseRate":0.25,"avgChangeRate":-0.042908},{"month":7,"riseRate":0.75,"avgChangeRate":0.027666},{"month":8,"riseRate":0.5,"avgChangeRate":0.043169},{"month":9,"riseRate":0.375,"avgChangeRate":0.03364},{"month":10,"riseRate":0.375,"avgChangeRate":-0.062011},{"month":11,"riseRate":0.25,"avgChangeRate":-0.026977},{"month":12,"riseRate":0.571429,"avgChangeRate":0.026236}],"exchange":"SEHK","name":"维亚生物","nameEN":"VIVA BIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维亚生物(01873)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维亚生物(01873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维亚生物,01873,维亚生物股票,维亚生物股票老虎,维亚生物股票老虎国际,维亚生物行情,维亚生物股票行情,维亚生物股价,维亚生物股市,维亚生物股票价格,维亚生物股票交易,维亚生物股票购买,维亚生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维亚生物(01873)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维亚生物(01873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}